Results 111 to 120 of about 23,180 (193)
Current issues in the treatment of visceral leishmaniasis. [PDF]
Bryceson, A
core +1 more source
Visceral leishmaniasis is a worldwide, disseminated intracellular protozoal infection that usually manifests by fever, hepatosplenomegaly, anemia, thrombocytopenia, leukopenia and hypergammaglobulinemia. Although anemia is a usual finding, Coombs'
Embiya Dilber +2 more
doaj
Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children
The aim of this study was to investigate the efficacy of a 21-day schedule of liposomal amphotericin B compared to pentavalent antimony salts in the treatment of patients during a first episode of visceral leishmaniasis. In this study, 17 cases of
Hurşit Apa +5 more
doaj
Liposomal amphotericin B in the treatment of pediatric gastrointestinal basidiobolomycosis. [PDF]
Forooghi M +5 more
europepmc +1 more source
Can liposomal amphotericin B be used as a preventive measure for cryptococcal meningitis? [PDF]
Schwartz EL, Bahr NC, Rajasingham R.
europepmc +1 more source
Liposomal amphotericin B and renal safety: review of the evidence and clinical considerations. [PDF]
Maertens J +4 more
europepmc +1 more source
Successful desensitization to liposomal amphotericin B for the treatment of disseminated cryptococcosis in pregnancy: a case report. [PDF]
Ajao SO +7 more
europepmc +1 more source
Liposomal amphotericin B prophylaxis in paediatrics: a systematic review. [PDF]
Thorley EV +9 more
europepmc +1 more source

